What are the new demands on disease management programs?
Which regulatory agencies are responsible for these demands? Are there risks to the demands and are there behavior limitations to these management programs?
In your discussion, provide examples of two successful Disease Management Programs from real life. Why were these programs successful? Can they be replicated in other settings? What are the challenges to replication?
Utilize a minimum of two scholarly and/or peer-reviewed sources that were published within the last five years, to support the ideas you express in your post.